189 related articles for article (PubMed ID: 17253799)
1. Solid-phase synthesis of thermolytic DNA oligonucleotides functionalized with a single 4-hydroxy-1-butyl or 4-phosphato-/thiophosphato-1-butyl thiophosphate protecting group.
Grajkowski A; Ausín C; Kauffman JS; Snyder J; Hess S; Lloyd JR; Beaucage SL
J Org Chem; 2007 Feb; 72(3):805-15. PubMed ID: 17253799
[TBL] [Abstract][Full Text] [Related]
2. Design and development of thermolytic DNA oligonucleotide prodrugs.
Grajkowski A; Pedras-Vasconcelos J; Ausín C; Verthelyi D; Beaucage SL
Ann N Y Acad Sci; 2005 Nov; 1058():26-38. PubMed ID: 16394123
[TBL] [Abstract][Full Text] [Related]
3. Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs.
Grajkowski A; Pedras-Vasconcelos J; Wang V; Ausín C; Hess S; Verthelyi D; Beaucage SL
Nucleic Acids Res; 2005; 33(11):3550-60. PubMed ID: 15972797
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent thermocontrol of the hydrophilic and lipophilic properties of DNA oligonucleotide prodrugs.
Ausín C; Grajkowski A; Cieślak J; Gapeev A; Beaucage SL
Curr Protoc Nucleic Acid Chem; 2010 Dec; Chapter 4():Unit 4.42.. PubMed ID: 21154531
[TBL] [Abstract][Full Text] [Related]
5. Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates.
Puig M; Grajkowski A; Boczkowska M; Ausín C; Beaucage SL; Verthelyi D
Nucleic Acids Res; 2006; 34(22):6488-95. PubMed ID: 17130156
[TBL] [Abstract][Full Text] [Related]
6. Thermolytic properties of 3-(2-pyridyl)-1-propyl and 2-[N-methyl-N-(2-pyridyl)]aminoethyl phosphate/thiophosphate protecting groups in solid-phase synthesis of oligodeoxyribonucleotides.
Cieślak J; Beaucage SL
J Org Chem; 2003 Dec; 68(26):10123-9. PubMed ID: 14682709
[TBL] [Abstract][Full Text] [Related]
7. Thermolytic 4-methylthio-1-butyl group for phosphate/thiophosphate protection in solid-phase synthesis of DNA oligonucleotides.
Cieślak J; Grajkowski A; Livengood V; Beaucage SL
J Org Chem; 2004 Apr; 69(7):2509-15. PubMed ID: 15049652
[TBL] [Abstract][Full Text] [Related]
8. The 4-methylthio-1-butyl group for phosphate/thiophosphate protection in oligodeoxyribonucleotide synthesis.
Cieślak J; Grajkowski A; Livengood V; Beaucage SL
Curr Protoc Nucleic Acid Chem; 2004 Dec; Chapter 3():Unit 3.11. PubMed ID: 18428926
[TBL] [Abstract][Full Text] [Related]
9. Thermolytic release of covalently linked DNA oligonucleotides and their conjugates from controlled-pore glass at near neutral pH.
Grajkowski A; Cieślak J; Kauffman JS; Duff RJ; Norris S; Freedberg DI; Beaucage SL
Bioconjug Chem; 2008 Aug; 19(8):1696-706. PubMed ID: 18646834
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs.
Jain HV; Takeda K; Tami C; Verthelyi D; Beaucage SL
Bioorg Med Chem; 2013 Oct; 21(20):6224-32. PubMed ID: 23755885
[TBL] [Abstract][Full Text] [Related]
11. An efficient reagent for the phosphorylation of deoxyribonucleosides, DNA oligonucleotides, and their thermolytic analogues.
Ausín C; Grajkowski A; Cieślak J; Beaucage SL
Org Lett; 2005 Sep; 7(19):4201-4. PubMed ID: 16146387
[TBL] [Abstract][Full Text] [Related]
12. Conceptual "Heat-Driven" approach to the synthesis of DNA oligonucleotides on microarrays.
Grajkowski A; Cieślak J; Chmielewski MK; Marchán V; Phillips LR; Wilk A; Beaucage SL
Ann N Y Acad Sci; 2003 Dec; 1002():1-11. PubMed ID: 14751818
[TBL] [Abstract][Full Text] [Related]
13. Linker phosphoramidite reagents for the attachment of the first nucleoside to underivatized solid-phase supports.
Pon RT; Yu S
Nucleic Acids Res; 2004; 32(2):623-31. PubMed ID: 14752050
[TBL] [Abstract][Full Text] [Related]
14. 31P NMR study of the desulfurization of oligonucleoside phosphorothioates effected by "aged" trichloroacetic acid solutions.
Cieślak J; Ausín C; Chmielewski MK; Kauffman JS; Snyder J; Del-Grosso A; Beaucage SL
J Org Chem; 2005 Apr; 70(8):3303-6. PubMed ID: 15823001
[TBL] [Abstract][Full Text] [Related]
15. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
Fonseca DE; Kline JN
Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
[TBL] [Abstract][Full Text] [Related]
16. The 3-(N-tert-butylcarboxamido)-1-propyl group as an attractive phosphate/thiophosphate protecting group for solid-phase oligodeoxyribonucleotide synthesis.
Wilk A; Chmielewski MK; Grajkowski A; Phillips LR; Beaucage SL
J Org Chem; 2002 Sep; 67(18):6430-8. PubMed ID: 12201764
[TBL] [Abstract][Full Text] [Related]
17. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
Zimmermann S; Dalpke A; Heeg K
Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
[TBL] [Abstract][Full Text] [Related]
18. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides.
Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA
Adv Drug Deliv Rev; 2009 Mar; 61(3):226-32. PubMed ID: 19162103
[TBL] [Abstract][Full Text] [Related]
19. O-selectivity and utility of phosphorylation mediated by phosphite triester intermediates in the N-unprotected phosphoramidite method.
Ohkubo A; Ezawa Y; Seio K; Sekine M
J Am Chem Soc; 2004 Sep; 126(35):10884-96. PubMed ID: 15339173
[TBL] [Abstract][Full Text] [Related]
20. 3-(N-tert-butylcarboxamido)-1-propyl and 4-oxopentyl groups for phosphate/thiophosphate protection in oligodeoxyribonucleotide synthesis.
Wilk A; Chmielewski MK; Grajkowski A; Beaucage SL; Phillips LR
Curr Protoc Nucleic Acid Chem; 2003 Feb; Chapter 3():3.9.1-3.9.16. PubMed ID: 18428905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
